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The incidence of lung adenocarcinoma has been remarkably increasing in recent years due to the introduction of ﬁlter
cigarettes and secondary-hand smoking because the people are more exposed to higher amounts of nitrogen oxides, especially
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone(NNK), which is widely applied in animal model of lung tumors. In NNK-
induced lung tumors, genetic mutation, chromosome instability, gene methylation, and activation of oncogenes have been found
so as to disrupt the expression proﬁles of some proteins or enzymes in various cellular signal pathways. Transgenic animal with
speciﬁc alteration of lung cancer-related molecules have also been introduced to clarify the molecular mechanisms of NNK in
the pathogenesis and development of lung tumors. Based on these animal models, many antioxidant ingredients and antitumor
chemotherapeutic agents have been proved to suppress the NNK-induced lung carcinogenesis. In the future, it is necessary to
delineate the most potent biomarkers of NNK-induced lung tumorigenesis, and to develop eﬃcient methods to ﬁght against
NNK-associated lung cancer using animalmodels.
1.Introduction
Throughout the spectrum of cancers worldwide, lung cancer
claims the lives of over one million people worldwide each
year and is one of the most common and lethal cancers
of men and women in North America, Europe, and East
Asia although current strategies in the treatment of lung
cancer including surgery, radiation therapy, chemotherapy,
and targeted biological therapies have slightly generated an
increase in the 5-year survival rate for all stages combined
[1]. The secular trend in lung cancer histology indicates
that the proportion or incidence of lung adenocarcinoma
has been increasing markedly over the past two decades,
surpassing the squamous cell carcinoma as the most com-
mon histological subtype of lung cancer in many countries,
which is partly dueto the introduction of ﬁltercigarettes and
secondary-smoking because the people are more exposed to
higher amounts of nitrogen oxides, nitrosated compounds,
and lung-speciﬁc smoke carcinogens [1–3].
Epidemiological and laboratory evidences demonstrate
a strong etiological association with smoking, which
contains volatile N-nitrosamines such as N-nitrosodimeth-
ylamine, N-nitrosopyrrolidine as well as tobacco-speciﬁc
N-nitrosamines such as N
 -nitrosonornicotine and 4-
(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
Although N
 -nitrosonornicotine causes tumors of the
oesophagus and nasal cavity in rats, NNK reproducibly
induces pulmonary adenocarcinomas (PAC) in laboratory
rodents, including rats, mice, hamsters, and ferrets, which
therefore has been classiﬁed as a human lung carcinogen by
the International Agency for Research on Cancer working
group. Signiﬁcant incidences of tumors occurred in the
lungs of strain A/J progeny (24wk) and in the livers of male
C3B6F1 and Swiss progeny (72wk) after NNK treatment
[4]. NNK is known to be activated in the lung via α-carbon
hydroxylation by cytochrome P450 (CYP), hemoglobin, and
lipoxygenases (LOX)[5]. The production ofmethylating and
pyridyloxobutylating agents that attack DNA and cause the
geneticchangesisknowntobeassociatedwithselfsuﬃciency
in growth signals, evasion of apoptosis, insensitivity to
antigrowth signals, sustained angiogenesis, tissue invasion
and metastasis, and limitless replicative potential.
With lung carcinogenesis models, it may be helpful to
gain insights into basic biology of lung tumors, ﬁnd out
markers for early diagnosis, and validate antilung cancer2 Journal of Oncology
prevention and therapies. Ferrets exposed to both NNK and
smoke developed preneoplastic lesions (squamous metapla-
sia, dysplasia, and atypical adenomatous hyperplasia) with
complex growth patterns and further exposure will cause
squamous cell carcinoma, adenosquamous carcinoma, and
adenocarcinoma[6,7].InA/Jmice,14-weekNNKtreatment
can cause pulmonary hyperplasias along the alveolar septa,
in which the proliferating cells showed cuboidal shape,
lamellarbodies,andcentrallylocalizedovoidnucleiastypeII
pneumocytes.From34to42wksaftertreatment,progression
toneoplasia was characterized byadeclinedhyperplasias and
an increased adenoma. Carcinomas appeared to increase in
frequency 34wks after NNK treatment and comprised more
than 50% of the pulmonary lesions by 54wks. The growth
pattern of carcinomas began to change from solid to mixed
(solid and papillary) 42wks after NNK treatment [8].
2.Mechanisms of NNK-Induced
LungCarcinogenesis
The establishment of genetic and epigenetic alteration
followed by gene expression proﬁling is of great use and
help to clarify molecular mechanisms of NNK-induced lung
tumorigenesis. In experimental model, NNK could cause
Adrb2 SNP mutation of Syrian golden hamsters, and K-
ras mutation in codon 12 of the A/J mice [9–11]. Bacterial
artiﬁcial chromosome array-based comparative genomic
hybridization indicated that the gains on chromosomes 6
and 8, and losses on chromosomes 11 and 14, were more
common in NNK-induced tumors and the changes on
chromosomes 8, 11, 12, and 14 were positively associated
with the degree of chromosome instability [12, 13]. The
methylation of the retinoic acid receptor (RAR)-β and
death-associated protein kinase gene was also detected in
preneoplastic hyperplasias or adenocarcinoma induced by
NNK treatment [14–16].
NNK administration reduced the miR-126∗ expression
targeting CYP2A3 in rat lungs, but induced CYP2A3 expres-
sion [17]. The 14-3-3 isoforms (θ, ξ,a n dσ) and annexin
A5 were signiﬁcantly downregulated in NNK-induced pul-
monary adenocarcinogenesis of A/J mice according to 2D-
electrophoresis[18].Immunohistochemically, NNKinduced
preneoplastic lesions in lungs, including alveolar hyperplasia
and atypical dysplasia with COX-2 and PCNA overex-
pression [19]. In lung adenocarcinoma of hamsters, the
overexpression of PKA, cAMP, CREB and phosphorylated
CREB in β2-adrenergic receptor pathway and EGFR-speciﬁc
phosphorylated tyrosine kinase, Raf-1 and ERK1/2 and their
phosphorylated forms in EGFR pathway were observed [20].
Regarding the control of cell cycle, there was an upregulated
expression of cyclin D1 and cdk4, but downregulated Rb
expression in NNK-induced lung adenomas and adenocar-
cinomas [21]. Exposure of NNK to hamsters and mice led to
thedecreasedexpressionofClaracell10-kDaprotein(CC10)
which subsequently enhances the induction of anchorage-
independent growth in response to NNK [22]. The NNK
treatment enhanced the expression of fatty acid synthase,
transketolase, pulmonary surfactant-associated protein C,
L-plastin, annexin A1, and haptoglobin, but the expres-
sion of transferrin, α-1-antitrypsin, and apolipoprotein A-
1 decreased [23]. The NNK-mediated expression of protein
and RNA in mouse lung tumors will provide more informa-
tionandcluesaboutmarkersofNNK-inducedtumroigenesis
and targets for antipreventive agents in NNK-related lung
cancer.
3.Transgenic Animal Modelof NNK-Mediated
Lung Carcinoma
Transgenic models have the potential to play an important
role in identiﬁcation of potential human carcinogens and
clarify the molecular mechanisms of carcinogens in the
pathogenesis and development of malignancies. Actually,
many transgenic and knockout mice have been applied to
investigate the NNK-induced lung carcinogenesis.
When transgenic mice that overexpress HGF in the
airway epitheliumwere exposed toNNK,theyexhibitedcon-
gestion in the alveolar spaces, excessive production of blood
vessels, a convoluted pattern of airways with more number
of lung tumors, and high tumor incidence, compared with
control [24]. All NNK-treated SPC/myc transgenic mice
showed bronchioloalveolar hyperplasia and adenocarcinoma
formation[25].Thep53mutation,onanA/JF1background,
were more susceptible to NNK and mice with a mutant
p53 developedlargerlung tumors, emphasizing the potential
eﬀects of a p53 mutation both on tumor initiation and
progression [26].NNK-treatedmiceexpressing high levelsof
IGF-IR transgene developed larger tumors than the control
mice [27].
Galectin-3, a β-galactoside-binding lectin is a multifunc-
tional protein, which regulates cellular adhesion, prolifera-
tion, and apoptosis, and in turn contributes to tumorigene-
sis. We intraperitoneally administrated NNK into galectin-
3 wild-type (gal3+/+) and knockout (gal3−/−)m i c ea n d
found that the incidence of lung tumors was signiﬁcantly
lower in gal3−/− than gal3+/+ mice after 32wks. Compared
with gal3+/+ mice, pathway analysis of gene microar-
ray indicated that galectin-3 upregulated carcinogenesis-
related genes (e.g., B-cell receptor, ERK/MAPK, and PPAR
signalings) in normal condition, and NNK-induced gene
expression were associated with cellulargrowth(e.g.,Wnt/β-
catenin signaling) or immunological disease (e.g., EGF
and PDGF signalings) in lung carcinogenesis regardless of
galectin-3 status. The functions involved in NNK-induced
PAC include cellular growth and proliferation and canonical
pathways for Wnt/β-catenin signaling [28, 29].
Human methylguanine-DNA methyltransferase
(MGMT) transgenic mice overexpressing O6-alkylguanine-
DNA alkyltransferase (AGT) in lung were crossbred with
A/J mice for animal model of lung tumors. The MGMT
transgenic mice had higher AGT activity, lower multiplicity,
and smaller-sized lung tumors than the control mice after
NNK treatment. Moreover, a reduction in K-ras mutations
in lung tumors was found in the MGMT transgenic mice
[30]. When MGMT−/− mice were crossed with a lacI-based
transgenic reporter line, NNK-dependent lacI mutationsJournal of Oncology 3
was more frequently observed in MGMT−/− tissues. The
mutational spectra of NNK-treated MGMT−/− lungs
revealed an increase in G:C to A:T changes accompanied by
a shift from CpG to GpG sites [31]. 8-hydroxyguanine DNA
glycosylase 1 (Ogg1) gene encodes an enzyme that repairs
an oxidative DNA injury 8-oxoguanine (8-oxoG), whose
deﬁciency results in the development of lung adenomas and
preneoplastic atypical hypreplasias in knockout mice treated
with NNK [32].
There was a NNK-dose-dependent increase in lung
tumor size in PTEN+/−,c o m p a r e dw i t h+ / +m i c e .L u n g
tumors from PTEN+/− mice had K-ras mutations, low
PTENexpression,andAktpathwayactivation[33].Although
mice with a knockout of G-protein coupled receptor 5A
develop lung tumors after a long latent period, NNK
treatment could hurry the development of lung tumors,
exhibiting increased tumor incidence and multiplicity and a
dramatic increase in lesion size [34]. The 4 eukaryotic ini-
tiation factor (ebp)1−/−/4ebp2−/− mice showed increased
sensitivity to NNK-induced tumorigenesis, compared with
the wild-type counterparts due to translational activation of
genes governing angiogenesis, growth and proliferation and
translational activation of CYP2A5 [35]. NNK exposure of
CC1-knockout mice causes a signiﬁcantly higher incidence
of airway epithelial hyperplasia and lung adenomas with
K-ras mutation, Fas ligand expression and MAPK/ERK
phosphorylation increased than wild-type littermates [36].
The numbers of NNK-induced lung tumors and
tumor multiplicity were reduced in the lung-NADPH-P450-
reductase (Cpr)-null mice, relative to wild-type mice, which
was correlated with lower lung O6-methylguanine adduct
levels. Lung tumors in lung-Cpr-null mice were positive for
CPR expression, indicating that the tumors did not originate
fromCpr-nullcells[37].WiththeNNKtreatment,thetumor
multiplicityinangiotensin IItype2receptor(AT2)-nullmice
was signiﬁcantly smaller than that in wild-type mice [38].
4.Repressingof NNK-Induced
LungCarcinogenesis
The antioxidants (Selenium, β-carotene, N-acetylcysteine,
and α-tocopherol) from tea, plant, or vitamin can prevent
lung carcinogenesis in an NNK-treated ferret model by
preventing oxidative DNA damage, and increasing the levels
of lung retinoic acid in the lung cancer induced by NNK.
Chemotherapeutic agents also play a preventive role in the
NNK-inducedlungtumorigenesisdueto themodiﬁcationof
disrupted signal pathways.
4.1. Selenium. 1,4-phenylenebis(methylene)selenocyanate
(p-XSC) was highly eﬀective to inhibit the initiation and
postinitiation phase of lung tumorigenesis induced by NNK
in A/J mice and reduce NNK-induced DNA methylation
and 8-hydroxy-2 -deoxyguanosine (8-OHdG) levels in the
lung [39]. The levels of protein-bound:free GSH ratios and
Cys ratios were signiﬁcantly decreased, and total glutathione
S-transferase (GST) enzyme activity, as well as GST-pi and
GST-mu enzyme activities, glutathione peroxidase (GPX)
activity were signiﬁcantly induced in p-XSC-treated mice
after NNK treatment. These results suggest that p-XSC
inhibits tumor formation partially by protecting against
oxidative damage [40]. Additionally, p-XSC was shown to
signiﬁcantly inhibit formation of O6-methylguanine and
7-methylguanine in the mouse lungs treated with NNK,
indicating its inhibitory role in DNA methylation [41].
Additionally, 2-oxo-selenazolidine-4(R)-carboxylic acids
and selenocystine signiﬁcantly reduced lung adenoma
multiplicity in NNK-treated mice with hepatic selenium
levels elevated [42].
4.2. Tea. The inhibitory eﬀect of tea on lung carcinogen-
esis has been attributed to its major ingredients, such as
polyphenolic compound, epigallocatechin gallate (EGCG),
caﬀeine, thearubigins, and theaﬂavins because tea inhibited
the formation of reactive oxygen species and radicals, and
inducedCYP1A1,1A2and2B1,andglucuronosyltransferase
[43]. In NNK-induced lung tumors, tea treatment inhibited
angiogenesis, as indicated by the lower microvessel density
and enhanced the apoptosis index labeled by TUNEL
[44]. The levels of 8-hydroxydeoxyguanosine, a marker of
oxidative DNA damage, were signiﬁcantly suppressed in
NNK-induced mice treated with green tea or EGCG. The
oxidation products found in black tea, thearubigins, and
theaﬂavins, also possessed antioxidant activity and retarded
the development of lung cancer caused by NNK [45]. The
administration of Polyphenon E and Caﬀeine not only
reduced the incidence and multiplicity of lung adenocarci-
noma in femaleA/J miceinducedby NNK,butalso inhibited
cell proliferation, enhanced apoptosis, and lowered levels
of c-Jun and ERK1/2 phosphorylation in adenocarcinomas
and adenomas, suggesting thattea polyphenols(and perhaps
caﬀeine) inhibit NNK-induced lung tumorigenesis [46].
4.3. Vitamin. Vitamin E inhibits tumor cell growth in vitro
irrespective of its antioxidative eﬀect. In NNK-induced lung
tumorsofmice,VitaminEsupplementreducedthemutation
frequency of K-ras at codon 12, suggesting that it suppresses
NNK-induced DNA injury [47]. α-tocopheryloxybutyric
acid (TSE), a nonantioxidative vitamin E derivative, could
inhibit cell proliferation during the mouse lung tumorigenic
process treated with NNK. The administration of Vitamin
E or TSE suppressed the labeling index of the PCNA, the
elevation of ornithine decarboxylase activity at a promotion
phase of NNK-induced lung tumorigenesis [48, 49]. γ-
tocopherol-rich mixture of tocopherols (γ-TmT, considered
asvitaminE)signiﬁcantlyloweredtumormultiplicity,tumor
volume, and tumor burden, which was associated with high
apoptosis andlowlevelsof8-hydroxydeoxyguanine,γ-H2AX
and nitrotyrosine in the NNK-induced lung [50].
Mice receiving the supplementation of 1α,25-dihy-
droxyvitamin D3 (1,25D) had signiﬁcantly lower tumor
incidence and tumor multiplicity, but experienced body
weight loss, kidney calcium deposition, elevated kidney
CYP24 expression, and decreased fasting plasma 1,25Dlevels
[51]. Inhaled mid-dose isotretinoin (13-cis-retinoic acid)
caused up-regulation of lung tissue nuclear RARs relative4 Journal of Oncology
to vehicle-exposed mice [52]. 9-cis-Retinoic acid (9cRA)
binds both RARs and retinoid X receptors and has been
s h o w nt ob eap o t e n t i a lc h e m o p r e v e n t i v ea g e n t .T h em i c e
receiving 9cRA supplementation had signiﬁcantly lower
tumor multiplicity and showed a trend toward lower tumor
incidence, as compared with the mice given NNK alone
[53]. The mice exposed to the high isotretinoin (13-cis
retinoic acid) dose or 5-hydroxy-4-(2-phenyl-(E) ethenyl)-
2(5H)-furanone (KYN-54, a novel retinoidal butenolide
compound) showed reductions of tumor multiplicity after
NNK treatment [54].
4.4. Plant and Vegetable. The discovery of dietary-related
compounds with potential to inhibit lung cancer may
present promising and practical approaches to reduce the
risk of lung cancer caused by smoking. The exposure to
fermented brown rice and rice bran signiﬁcantly reduced the
multiplicity, and tumor size of NNK-induced lung tumor
with the expression of CYP 2A5 mRNA and Ki-67 protein
decreased[55].Deguelin,anaturalplantproduct,speciﬁcally
inhibits the proliferation of premalignant and malignant
bronchial epithelial cells by blocking Akt activation [56].
Feedingwithpowdered adlayseed exertsananticancereﬀect,
evidenced by the reduced number of surface lung tumors
[57]. The administration of Changkil saponins suppressed
the NNK-induced increase in the level of PCNA and the
number of lung tumors [58]. The treatment of 7-hydroxy-3-
methoxycadalene from Zelkova serrata signiﬁcantly reduced
the incidence of adenomas and adenocarcinoma in a
concentration-dependent manner [59]. Cinnamaldehyde
(CNMA) treatment signiﬁcantly reduced the combined
incidence of adenomas and carcinomas, tumor multiplicity
in transgenic rasH2 male mice [10]. Kava is a traditional
beveragein the SouthPaciﬁc islands and couldprevent NNK
plusBaP-induced lung tumorigenesisin A/Jmice by enhanc-
ing apoptosis, inhibiting proliferation and the activation of
NF-kappaB in lung tumors [60]. Isothiocyanates are derived
from cruciferous vegetables and their N-acetylcysteine and
phenethyl conjugates inhibit the formation of lung adenoma
and adenocarcinoma with a signiﬁcant reduction in PCNA
and an induction of apoptosis in A/J mice induced by
NNK [61, 62]. In (A/J × TSG-p53 “knockout”) F1 mice
with either the p53+/− or p53+/+ genotype, phenethyl
isothiocyanate (PEITC) pretreatment signiﬁcantly decreased
tumor incidence and multiplicity [63]. β-carotene increased
lung tumor multiplicity, lung tumor size, blood cell cAMP,
serum, and lung levels of retinoids and induced p-CREB and
p-ERK1/2 in PAC induced by NNK [64]. Treatments with
Satsuma mandarin juice (MJ), MJ2, and MJ5 reduced the
incidence and multiplicity of NNK-induced lung tumors by
decreasing PCNA-positive index in lung tumors [65].
4.5. Enzyme Inhibitor. CYP enzymes can catalyze the α-
hydroxylation of NNK for its activation in the oxidative
metabolism pathway, such as CYP2A6. A trend was noted
for8-Methoxypsoralen(8-MOP),aninhibitorofCYP2A6,to
reduceadenomasandadenocarciomatoagreaterextentthan
hyperplasia in mouse lung treated by NNK [66–69]. NNK
is reported to promote COX-2 activity in colon and gastric
cancercellsandthedevelopmentofNNK-inducedadenocar-
cinomas in mice is reduced by inhibitors of cyclooxygenase
[70]. Another report showed that such speciﬁc COX-2
inhibitors as acetylsalicylic acid or N-[2-(cyclohexyloxy)-
4-nitrophenyl]-methanesulfona-mide signiﬁcantly increased
the apoptotic index and inhibited the expression of COX-
2 in NNK-treated mice [71]. Farnesyltransferase inhibitors
(FTIs) included manumycin, gliotoxin, dihydroepiandros-
terone, perillyl alcohol, and FTI-276. FTI-276 reduced both
the tumor multiplicity and the total tumor volume/burden
per mouse. The apoptotic index in FTI-276-treated tumors
showed an increase of 77% over control tumors [72].
4.6. Fatty Acid. The supplementation of ﬁsh oil with a
low ω-6 (n-6)/ω-3 (n-3) polyunsaturated fatty acid ratio
was able to signiﬁcantly decrease lung tumor prevalence
compared to groups receiving soybean oil and corn oil,
which was associated with increased expression of cell cycle
inhibitor p21Cip1 and lipoxygenase isoform 15-LOX in the
lungs [73]. The treatment of NNK increased the level of
prostaglandin E2as well as PCNAand induced theactivation
of an ERK cascade (ERK, MEK, and Raf-1) in high linoleic
acid oil- (LA-) fed mice. On the other hand, oleic acid oil
(OA) feeding abolished the NNK-induced activation of the
ERK cascade. In conjugation with these events, OA feeding
reduced lung tumor incidence and tumor multiplicity in
mice compared with LA feeding. These results suggest that
OA suppresses lung tumorigenesis and that this suppression
is correlated with the inhibition of PGE2 production and
inactivation of the ERK cascade [74]. Myoinositol in AIN-93
diet also proved to reduce the development of lung tumors
induced by NNK [75].
4.7. Anticancer Reagents. The anticancer chemicals targeting
the cell signals and metabolism can be employed to pre-
vent carcinogenesis. Geﬁtinib is an EGFR tyrosine kinase
inhibitor (EGFR-TKI) and could signiﬁcantly suppress the
multiplicities of the NNK-induced tumors in a dose-
dependent manner [76]. The administration of Rapamycin,
an inhibitor of mTOR, decreased tumor size, proliferative
rate, tumor multiplicity, and mTOR activity in NNK-treated
mice [77]. Targretin is a retinoid speciﬁcally selective for
retinoid X receptors and widely used as an anticancer
reagent. In mice, it could decrease the multiplicity and
size of NNK-induced tumors, demonstrating its preventive
and therapeutic activity [78]. Histone deacetylase inhibitors,
such as suberoylanilide hydroxamic acid (SAHA), showed
a signiﬁcant inhibition of lung tumor multiplicity in mice
treated with NNK. However, a signiﬁcant inhibition of the
alpha-hydroxylation pathway of NNK was observed in lung
microsomes, suggesting that SAHA may act to inhibit the
activation pathways of NNK metabolism [79].
5.FuturePerspectives
The contribution of NNK to the imbalance between cellular
proliferation and apoptosis, and subsequent lung tumori-
genesis has been consistently described and conﬁrmed inJournal of Oncology 5
numerous animal models. According to animal experiments,
several mechanisms of NNK-induced lung carcinoma have
been proposed, including (i) the activation of oncogenes via
mutation, (ii) interruption and/or silencing of genes encod-
ing enzymes coupled with NNK, (iii) direct manipulation of
enzymes(speciﬁcally fromthe CYPprotein family) responsi-
ble for activation and initiation of NNK-mediated processes,
and (iv) thedisruption ofthe signal pathways. Some primary
preventive approaches have not yet been established, includ-
ing (i) rendering NNK inactivation by antioxidants (tea,
vegetable,vitaminandmetalcompunds)and(ii)obstructing
the function of NNK (anticancer chemotherapeutic agents).
In the recent years, too many transgenic mice has been
bred and applied in the establishment of lung cancer model,
which can provide an eﬃcient tool for the investigation of
lung cancer without the inﬂuence of chemical carcinogen. If
treated with NNK, it is of great help and use to clarify the
molecular mechanism of NNK-induced lung carcinogenesis
and ﬁnd out the novel target to prevent NNK-associated
lung cancer. Therefore, it is necessary to delineate the most
potent biomarkers of NNK-inducedlung tumorigenesis, and
to developeﬃcient methods to ﬁght against this kind of lung
cancer using animal model in the future.
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